Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
762.63
+24.29 (3.29%)
At close: Jul 31, 2026, 4:00 PM EDT
761.45
-1.18 (-0.16%)
After-hours: Jul 31, 2026, 7:49 PM EDT

Regeneron Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
76,15281,58778,07196,08579,07568,631
Market Cap Growth
27.18%4.50%-18.75%21.51%15.22%33.09%
Enterprise Value
61,03675,68771,76387,94374,03465,636
Last Close Price
762.63771.87712.33878.29721.49631.52
PE Ratio
18.8618.6118.5825.2618.888.77
Forward PE
12.5817.1115.1919.3617.2911.00
PEG Ratio
1.062.930.954.755.865.17
PS Ratio
4.905.695.507.336.504.27
PB Ratio
2.412.612.663.703.493.66
P/TBV Ratio
2.692.792.914.013.773.78
P/FCF Ratio
20.2519.9921.3024.7917.8710.51
P/OCF Ratio
16.2716.3917.6620.9215.779.69
EV/Sales Ratio
3.935.285.056.706.084.08
EV/EBITDA Ratio
13.9618.3616.0419.6814.577.11
EV/EBIT Ratio
15.8821.1517.9821.7315.627.34
EV/FCF Ratio
16.2318.5519.5822.6916.7310.05
Debt / Equity Ratio
0.060.090.090.100.120.11
Debt / EBITDA Ratio
0.620.660.610.610.530.29
Debt / FCF Ratio
0.720.660.740.700.610.41
Net Debt / Equity Ratio
-0.17-0.19-0.21-0.31-0.22-0.16
Net Debt / EBITDA Ratio
-1.21-1.43-1.41-1.82-0.99-0.32
Net Debt / FCF Ratio
-1.41-1.45-1.72-2.10-1.14-0.46
Asset Turnover
0.380.370.400.420.450.75
Inventory Turnover
0.750.670.700.730.721.26
Quick Ratio
2.633.283.864.824.162.98
Current Ratio
3.344.134.735.695.063.56
Return on Equity (ROE)
13.75%14.87%15.95%16.26%20.94%54.21%
Return on Assets (ROA)
7.83%7.87%10.40%12.23%15.49%36.37%
Return on Invested Capital (ROIC)
12.43%12.73%18.02%21.49%25.34%59.80%
Return on Capital Employed (ROCE)
10.62%10.22%12.57%14.52%19.92%49.75%
Earnings Yield
5.68%5.37%5.38%3.96%5.30%11.40%
FCF Yield
4.94%5.00%4.69%4.03%5.60%9.51%
Dividend Yield
0.49%0.46%0.00%0.00%0.00%0.00%
Payout Ratio
9.15%8.22%0.00%0.00%0.00%0.00%
Buyback Yield / Dilution
4.76%5.65%-1.23%-0.18%-1.16%2.52%
Total Shareholder Return
5.25%6.11%-1.23%-0.18%-1.16%2.52%
SEC Filings: 10-K · 10-Q